| Preface |
|
v | |
| USP People 1995--2001 |
|
vii | |
| Officers, Board of Trustees, General Committee of Revision |
|
vii | |
| Executive Committee of Revision, Division of Information Development Executive Committee, Division of Standards Development Executive Committee, Drug Nomenclature Committee |
|
viii | |
| Information Development Advisory Panels |
|
ix | |
| Division of Information Development Additional Contributors |
|
xiii | |
| Members of the United States Pharmacopeial Convention |
|
xiii | |
|
Approved Drug Products with Therapeutic Equivalence Evaluations |
|
|
1 | (1) |
|
|
|
3 | (2) |
|
|
|
5 | (1) |
|
|
|
6 | (11) |
|
How to Use the Drug Product Lists |
|
|
17 | (3) |
|
|
|
20 | (581) |
|
Prescription Drug Products |
|
|
20 | (296) |
|
|
|
316 | (12) |
|
Drug Products with Approval under Section 505 of the Act Administered by the Center for Biologics Evaluation and Research List |
|
|
328 | (5) |
|
Discontinued Drug Products |
|
|
333 | (172) |
|
Orphan Product Designations and Approvals |
|
|
505 | (95) |
|
Drug Products Which Must Demonstrate in vivo Bioavailability Only If Product Fails to Achieve Adequate Dissolution |
|
|
600 | (1) |
|
Appendix A: Product Name Index |
|
|
601 | (44) |
|
Appendix B: Product Name Index Listed by Applicant |
|
|
645 | (95) |
|
Appendix C: Uniform Terms |
|
|
740 | (1) |
|
Patent and Exclusivity Information Addendum |
|
|
741 | |
|
|
|
1 | (1) |
|
Listing of ``Pre-1938'' Products |
|
|
1 | (1) |
|
Chemistry and Compendial Requirements |
|
|
1 | (1) |
|
|
|
1 | (1) |
|
Container Specifications For Capsules and Tablets |
|
|
1 | (1) |
|
Selected USP General Notices and
Chapters |
|
|
1 | (1) |
|
Selected General Notices and Requirements |
|
|
1 | (8) |
|
|
|
9 | (2) |
|
|
|
11 | (1) |
|
|
|
11 | (2) |
|
|
|
13 | (6) |
|
<85> Bacterial Endotoxins Test |
|
|
19 | (4) |
|
|
|
23 | (7) |
|
<671> Containers---Permeation |
|
|
30 | (2) |
|
<751> Metal Particles in Ophthalmic Ointments |
|
|
32 | (1) |
|
<771> Ophthalmic Ointments |
|
|
32 | (1) |
|
|
|
32 | (1) |
|
<795> Pharmacy Compounding |
|
|
33 | (4) |
|
<1091> Labeling of Inactive Ingredients |
|
|
37 | (1) |
|
|
|
37 | (1) |
|
|
|
38 | (1) |
|
<1151> Pharmaceutical Dosage Forms |
|
|
38 | (13) |
|
<1176> Prescription Balances and Volumetric Apparatus |
|
|
51 | (1) |
|
<1191> Stability Considerations in Dispensing Practice |
|
|
52 | (3) |
|
<1206> Sterile Drug Products for Home Use |
|
|
55 | (13) |
|
<1211> Sterilization and Sterility Assurance of Compendial Articles |
|
|
68 | (5) |
|
|
|
73 | (1) |
|
<1231> Water for Pharmaceutical Purposes |
|
|
74 | |
|
Selected Laws and Regulations |
|
|
1 | (1) |
|
Federal Food, Drug, and Cosmetic Act Requirements Relating to Drugs for Human and Animal Use and to Dietary Supplements |
|
|
1 | (34) |
|
Good Manufacturing Practices |
|
|
35 | (10) |
|
Subpart B---Compounded Drug Products |
|
|
45 | |
|
Poison Control Center Listing |
|
|
1 | (1) |
|
USP Practitioners' Reporting Network |
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
1 | |
